TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Stanford University
Stanford University
Thomas Jefferson University
University of Alabama at Birmingham
University of Turin, Italy
Ohio State University Comprehensive Cancer Center
University of Rochester
M.D. Anderson Cancer Center
University of Southern California
City of Hope Medical Center
University Hospital, Brest
Icahn School of Medicine at Mount Sinai
University of Washington
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
University of California, Irvine
City of Hope Medical Center
Massachusetts General Hospital
Dartmouth-Hitchcock Medical Center
Fred Hutchinson Cancer Center
Azienda Ospedaliero-Universitaria di Parma
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas
Washington University School of Medicine
Dana-Farber Cancer Institute
Brigham and Women's Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
Icahn School of Medicine at Mount Sinai
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
University of Virginia